Breast cancer is the most common cancer in American women. Currently, the average risk of a woman in the United States developing breast cancer is about 12%.

New York Cancer & Blood Specialists (NYCBS) is pleased to announce that Dr. Bartosz A. Walczyszyn, a board-certified hematologist-oncologist, has joined our innovative and dedicated network of physicians. Dr. Walczyszyn distinguishes himself with a distinct passion for cancer care. Dr. Walczyszyn joined our practice on December 1st and will practice at our Central Park location.

In a study reported in the Journal of Oncology Practice, Gordan et al found that costs of care for patients with breast, colorectal, and lung cancers were significantly higher at hospital-based vs community-based clinics, largely reflecting higher costs of chemotherapy and provider visits.

Dr. Lynn Ratner is an ABIM-certified Medical Oncologist, who received his M.D. license in 1970, from Albert Einstein School of Medicine in 1964.

New York Cancer & Blood Specialists (NYCBS) is pleased to announce that Dr. Leno Thomas has joined our innovative and dedicated network of physicians. For patients and loved ones, the fight against cancer or a complicated or sometimes even a benign, but cumbersome hematological disorder is a life-altering challenge.

No one is more committed to raising awareness of breast cancer every October than the New York Cancer and Blood Specialists team. As a community-based cancer care practice, we both talk the talk and walk the walk. Literally.

New York Cancer & Blood Specialists (NYCBS) is pleased to announce that Dr. Shabeer A. Dar is joining our innovative and dedicated network of physicians, as a certified Hematologist – Oncologist. Dr. Dar has been working as a certified Hematologist-Oncologist at Southside Hospital Bayshore—Northwell Health and Good Samaritan Hospital Medical Center of Catholic Health Services, for the past 23 years.

Oncologists Express Concerns About Patient Access to Cancer Treatment With Potential Introduction of Middlemen to Medicare Part B

They are spending hundreds of millions to open new locations, update technology and add staff in order to deliver quality care and operate in a highly competitive market.

General Atlantic Takes Majority Stake in OneOncology, a Startup for Running Cancer-Doctor Practices $200 million deal by private-equity firm is latest sign investors see opportunity in the health-services sector